In this episode of Spilling the Tea, we talk with David Satchell of Satch Medical Consulting about how large diagnostics companies and startups alike are addressing the drive towards near-patient testing.

Removing bottlenecks around media formulation, viral vector preparation and unique cell therapy reagents.

How Hugh Counsell's epic 5-year wooden boat restoration project led to a career in mechanical engineering

In this episode of Spilling the Tea, we talk with Peggy Robinson of Caza Health about fundraising during the pandemic, venture capital and grant trends post-COVID, keeping your vision and when to pivot as a startup.

Panelists from Acepodia, Celyad and SOTIO discuss how cell therapies are impacted by the high cost of manufacturing and share their insights on ways to drive down costs.

In this episode of Spilling the Tea, we talk with Steve Lufkin of Selux Diagnostics about building a company culture during a pandemic, changes in the antibiotic susceptibility testing (AST) market and the current fundraising environment.

In the first episode of our new “Spilling the Tea” interview series, we talk with Joen Johansen of MDC Associates about government and private partnerships and the future of complex POC tests.

Post COVID-19, accelerated development timelines, flexible manufacturing and the elevated role of the supply chain will be product development best practices.

From the back of the napkin to the bedside: Panelists from CUTISS, Humacyte and TreeFrog Therapeutics share their inspirational journeys commercializing disruptive technologies

Download this guide + checklist to learn how to accelerate manufacturing ramp-up, increase product quality and reduce material and labor costs.

How smart, connected Point of Care devices improve efficiencies, reduce development costs and provide competitive advantage through differentiation.

To develop a successful POC device, product developers need to accurately translate a laboratory assay workflow into a cartridge configuration.